Stock Track | ANGELALIGN Soars 5.40% Intraday on MDR-CE Certification for EU Market Access

Stock Track
01/08

ANGELALIGN (06699) surged 5.40% during Thursday's intraday session, reflecting strong investor optimism following the company's recent regulatory milestone.

The clear aligner specialist obtained the MDR-CE certificate from TÜV SÜD, confirming its products meet the EU's stringent Medical Device Regulation requirements. This certification marks a critical step in ANGELALIGN's international expansion, as it enables access to high-standard European markets and enhances the company's global credibility.

CEO Hu Jiezhang highlighted that international cases now represent over 50% of total case volume, with operations spanning 60+ countries. The MDR-CE certification is expected to further strengthen ANGELALIGN's competitive position in the global clear aligner market.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10